31/03/2004 (Agence Europe) - On Wednesday, the European Commission authorised the acquisition by Johnson & Johnson of the 50% stake held by Merck & Co in their joint venture Johnson & Johnson MSD Europe, a manufacturer to pharmaceutical products sold without prescription. The Commission has investigated the impact of this operation on the markets where the parties are present, especially on the vertical integration of the main active ingredients produced by Johnson & Johnson, and the...